98%
921
2 minutes
20
Introduction: According to the Center for Disease Control and Prevention, overdose deaths increased by only 0.5% in 2022 for the general population. However, adolescent overdose deaths increased 94% from 2019 to 2020 and 20% from 2020 to 2021. Addiction medicine consultation teams can help alleviate this disparity and other consequences of substance use. This study assessed how frequent addiction medicine consultations, harm reduction, or counseling/education on substance use disorders was provided to adolescents with a substance use disorder presenting to an emergency department.
Methods: A retrospective cohort study of adolescents 19 years or younger with an International Classification of Disease, tenth edition (ICD-10) diagnosis of a substance use disorder noted in their medical record when visiting the emergency department from 2019 to 2021.
Results: Three hundred and fifteen emergency department visits were made by 286 adolescents with substance use disorders. An addiction medicine consultation was completed in 1.2% of all visits. Harm reduction was provided at 8.5% of substance use-related visits and naloxone prescribed at 3.4% of substance use-related visits. Counseling/education was provided at 39% of substance use related visits. Patients with a substance use related involuntary hold were more likely to receive harm reduction (28.6% vs. 3.7%, = .003). Patients that received an addiction medicine or psychiatry consultation were more likely to receive counseling/education (45.8% vs. 22.8%, < .001).
Conclusions: Future studies need to examine hospital providers' reasons for not consulting addiction medicine specialists or providing harm reduction services for adolescents with substance use disorders.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1080/10826084.2025.2508742 | DOI Listing |
J Behav Health Serv Res
September 2025
Adolescent Behavioral Health Research Program, Indiana University School of Medicine, Indianapolis, IN, USA.
Evidence-based practices (EBPs) are most effective when they are delivered with a high degree of fidelity, or as they are intended to be delivered. Because clinicians often deviate from fidelity, it is important to monitor EBP fidelity over time to guide corrective actions. However, little is known about current fidelity monitoring practices in community behavioral health care.
View Article and Find Full Text PDFMol Psychiatry
September 2025
Nencki Institute of Experimental Biology of Polish Academy of Sciences, 3 Pasteur St., Warsaw, 02-093, Poland.
Alcohol use disorder (AUD) is characterized by pathological motivation to consume alcohol and cognitive inflexibility, leading to excessive alcohol seeking and use. In this study, we investigated the molecular correlates of impaired extinction of alcohol seeking during forced abstinence using a mouse model of AUD in the automated IntelliCage social system. This model distinguished AUD-prone and AUD-resistant animals based on the presence of ≥2 or <2 criteria of AUD, respectively.
View Article and Find Full Text PDFMol Psychiatry
September 2025
Section on Clinical Genomics and Experimental Therapeutics, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD, USA.
Pharmacological modulation of glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) through dual GIP/GLP-1 receptor agonists, commonly used for diabetes and obesity, shows promise in reducing alcohol consumption. We applied drug-target Mendelian randomization (MR) using genetic variation at these loci to assess their long-term effects on problematic alcohol use (PAU), binge drinking, alcohol misuse classifications, liver health, and other substance use behaviors. Genetic proxies for lowered BMI, modeling the appetite-suppressing and weight-reducing effects of variants in both the GIPR and GLP1R loci ("GIPR/GLP1R"), were linked with reduced binge drinking in the primary (β = -0.
View Article and Find Full Text PDFJ Am Acad Psychiatry Law
September 2025
Dr. Dernbach is a medical toxicologist and current addiction psychiatry fellow, Department of Psychiatry, Harvard Medical School, Boston, MA. Dr. Appel is a Professor of Psychiatry and Medical Education, Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY.
Clinicians face the prospect of mandated reporting when a patient reports, either during the intake appointment or during the course of addiction treatment, their risky substance use-related behavior around a child. Beyond legal considerations, many factors might influence a clinician's decision whether or not to report the case to child protective services (CPS). Although there is literature regarding mandated reporting in the setting of pre- or perinatal substance use, there is limited literature regarding the mandated reporting obligation in the setting of postnatal substance use around children.
View Article and Find Full Text PDFJ Affect Disord
September 2025
Department of Radiology and Biomedical Imaging, Yale University, New Haven, CT, USA; Department of Psychiatry, Yale School of Medicine, New Haven, CT, USA; Department of Neurology, Yale University, New Haven, CT, USA. Electronic address:
Purpose: Dopamine is a neurotransmitter implicated in functions ranging from motor control to cognitive performance. In humans, dopaminergic markers have been associated with seasonal symptomatic fluctuations. Here we investigated potential seasonal variations in dopamine D2/D3 receptor availability in healthy adults using [C]PHNO positron emission tomography (PET) imaging.
View Article and Find Full Text PDF